NEW YORK, June 1, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at
Monteverde & Associates PC, a boutique securities firm
headquartered at the Empire State Building in New York City, announces that a class action
lawsuit has been filed in United States District Court for the
Central District of California
against ImmunoCellular Therapeutics (NYSE MKT:
IMUC)("ImmunoCellular Therapeutics" or the "Company") on behalf of
purchasers of the Company's securities between May 1, 2012 and December
11, 2013, inclusive (the "Class Period").
The lawsuit is based on whether ImmunoCellular Therapeutics and
its executives violated federal securities law by issuing false
and/or misleading statements that ImmunoCellular retained Lidingo
Holdings, LLC to publish articles designed to unlawfully promote
the Company. Investors were led to believe that the Company's
clinical studies for its lead product candidate, ICT-107 were going
well in order to inflate ImmunoCellular's share price.
After market close on December 11,
2013, the Company revealed that the primary endpoint for its
ICT-107 Phase II study "did not reach statistical significance"
because it failed to increase overall survival in patients
diagnosed with glioblastoma multiforme. When the information was
revealed to the public, the value of ImmunoCellular stock dropped,
causing losses to its shareholders.
Mr. Monteverde would like to personally discuss with you how
to potentially recover your monetary losses, if incurred during the
Class Period.
If you wish to serve as lead plaintiff, you must move the Court
no later than June 30,
2017. Any member of the putative class may move
the Court to serve as lead plaintiff through counsel of their
choice, or may choose to do nothing and remain an absent class
member.
Click here for more information:
http://monteverdelaw.com/securities/. It is free
and there is no cost or obligation to you.
Monteverde & Associates PC is a boutique class action
securities and consumer litigation law firm committed that has
recovered millions of dollars and is committed to protecting
shareholders and consumers from corporate wrongdoing.
Monteverde & Associates PC lawyers have significant experience
litigating Mergers & Acquisitions and Securities Class Actions,
whereby they protect investors by recovering money and remedying
corporate misconduct.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates
PC. Prior results do not guarantee a similar outcome with
respect to any future matter.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-invites-immunocellular-therapeutics-ltd-shareholders-with-losses-to-contact-the-firm-immediately---imuc-300467445.html
SOURCE Monteverde & Associates PC